NasdaqCM - Nasdaq Real Time Price • USD
Avenue Therapeutics, Inc. (ATXI)
As of 11:52 AM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.12 | -0.1 | -0.41 | -0.37 |
| Low Estimate | -0.12 | -0.1 | -0.41 | -0.37 |
| High Estimate | -0.12 | -0.1 | -0.41 | -0.37 |
| Year Ago EPS | -1.35 | -0.52 | -0.98 | -0.41 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -0.13 | -0.29 | -0.26 | -0.1 |
| EPS Actual | -1.35 | -0.52 | 0.06 | 0.06 |
| Difference | -1.22 | -0.23 | 0.32 | 0.16 |
| Surprise % | -938.50% | -79.30% | 123.10% | 160.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.1 | -0.41 | -0.37 |
| 7 Days Ago | -0.12 | -0.1 | -0.41 | -0.37 |
| 30 Days Ago | -0.12 | -0.1 | -0.41 | -0.37 |
| 60 Days Ago | -0.12 | -0.1 | -0.41 | -0.37 |
| 90 Days Ago | -0.12 | -0.1 | -0.41 | -0.37 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | ATXI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 91.10% | -- | -- | 1.50% |
| Next Qtr. | 80.80% | -- | -- | 12.10% |
| Current Year | 58.20% | -- | -- | 4.40% |
| Next Year | 9.80% | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Initiated | Maxim Group: Buy | 12/11/2023 |
| Initiated | Aegis Capital: Buy | 4/3/2023 |
Related Tickers
FBIO Fortress Biotech, Inc.
1.7300
+0.58%
NBY NovaBay Pharmaceuticals, Inc.
0.0850
+10.39%
FWBI First Wave BioPharma, Inc.
2.5900
-5.13%
RNAZ TransCode Therapeutics, Inc.
0.5289
+1.28%
BPTS Biophytis S.A.
8.22
0.00%
ALLR Allarity Therapeutics, Inc.
1.5194
+6.25%
KTRA Kintara Therapeutics, Inc.
0.1516
-4.07%
CKPT Checkpoint Therapeutics, Inc.
1.4150
-0.35%
ZVSA ZyVersa Therapeutics, Inc.
4.8800
-18.67%
FBIOP Fortress Biotech, Inc.
13.77
+2.46%